Mangoceuticals, Inc. Accumulated Other Comprehensive Income
Mangoceuticals, Inc. (MGRX) had Accumulated Other Comprehensive Income of -$5.20 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$5.20K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.19K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.76K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.08K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$5.20K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$3.19K 10-Q · filed 2026-05-19 |
| 2025-12-31 | -$2.76K 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$2.08K 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$2.03K 10-Q/A · filed 2025-11-14 |
| 2025-03-31 | -$2.22K 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$9.85K 10-K · filed 2026-04-01 |
| 2024-09-30 | -$1.66K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$1.17K 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$70.00 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |